FDA Alerts the Public of Serious Health Risks Associated with Que She Herbal Weight Loss Capsules
On July 8, 2010, the U.S. Food and Drug Administration (FDA) issued an alert regarding Que She tablets, an herbal dietary supplement sold primarily on the Internet. This product has been determined to contain several stimulant drugs, including those that have been banned by the FDA.
The use of Que She may cause serious and potentially life-threatening complications for users who are taking other prescription and/or over-the-counter medications.
The FDA’s press release follows here.
The U.S. Food and Drug Administration today warned that Que She, marketed as an herbal weight loss supplement, contains active pharmaceutical ingredients not listed on the product label that could harm consumers, especially those with cardiovascular conditions.
People who have purchased Que She should stop taking the product immediately and consult a health care professional.
Que She, advertised as “Slimming Factor Capsule” and as “an all-natural blend of Chinese herbs,” has been widely distributed on Internet sites such as the Bouncing Bear Botanicals website, and at retail outlets, including Sacred Journey in Lawrence, Kansas.
An FDA analysis of Que She found that it contains:
Fenfluramine – a stimulant drug withdrawn from the U.S. market in 1997 after studies demonstrated that it caused serious heart valve damage
Propranolol – a prescription beta blocker drug that can pose a risk to people with bronchial asthma and certain heart conditions
Sibutramine – a controlled substance and prescription weight loss drug, Sibutramine was the subject of a recent study whose preliminary findings showed an association between Sibutramine use and increased risk of heart attack and stroke in patients who have a history of heart disease
Ephedrine – a stimulant drug that is legally marketed over-the-counter for temporary relief of asthma but can pose a risk to people with certain cardiovascular conditions.
These active pharmaceutical ingredients also may interact with other medications and result in a serious adverse event.
Consumers and health care professionals are encouraged to report adverse events related to the use of Que She to the FDA's MedWatch Safety Information and Adverse Event Reporting Program at the MedWatch Web site.
Que She Capsules 
FDA information about Que She dietary supplements | Weitz & Luxenberg
Drug safety information from our lawyers: Recall of Que She, a dangerous dietary supplement sold over the Internet.
S-DROL Information from our law firm about the Nutracoastal recall of S-DROL
FDA announces recall of S-DROL supplements from Nutracoastal Trading
Dietary Supplements FDA announces recall of dietary supplements containing Sibutramine
Sibutramine found in CA company's over the counter dietary supplements
